Additionally, the newest rendition (5th edition) of the WHO Classification of hematolymphoid tumors categorizes acute leukemias with ZNF384 rearrangement or BCL11B rearrangement under acute leukemia of ambiguous lineage with defining genetic abnormalities, even if they qualify as MPAL phenotypically. The gene discussed is ZNF384; the disease is mixed phenotype acute leukemia.